Skip to main content
SpringerLink
Log in

Impatto della diagnosi citologica TIR3a sulle decisioni dell’endocrinologo

  • TIROIDE
  • Published:
L'Endocrinologo Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Bibliografia

  1. Pacini F, Basolo F, Bellantone R et al. (2018) Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies. J Endocrinol Invest 41(7):849–876

    Article  CAS  Google Scholar 

  2. Valderrabano P, McGettigan MJ, Lam CA et al. (2018) Thyroid nodules with indeterminate cytology: utility of the American Thyroid Association sonographic patterns for cancer risk stratification. Thyroid 28(8):1004–1012

    Article  Google Scholar 

  3. Fadda G, Rossi ED, Raffaelli M et al. (2011) Follicular thyroid neoplasms can be classified as low and high risk according to HBME-1 and Galectin 3 expression on liquid based fine needle cytology. Eur J Endocrinol 165:447–453

    Article  CAS  Google Scholar 

  4. Giordano TJ (the Cancer Genome Atlas Research Network) (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159(3):676–690

    Article  Google Scholar 

  5. Straccia P, Brunelli C, Rossi ED et al. (2019) The immunocytochemical expression of VE-1 (BRAF V600E-related) antibody identifies the aggressive variants of papillary thyroid carcinoma on liquid-based cytology. Cytopathology 30(5):460–467

    Article  Google Scholar 

  6. Vuong HG, Altibi AM, Duong UN, Hassell L (2017) Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis. Clin Endocrinol (Oxf) 87(5):411–417

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Scienze della salute della donna, del bambino e di sanità pubblica, Area clinica di Anatomia Patologica, Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italia

    Guido Fadda

  2. Dipartimento di Scienze Mediche, Chirurgiche e Neuroscienze, UOC di Endocrinologia, Policlinico Santa Maria alle Scotte, Università di Siena, Siena, Italia

    Maria Grazia Castagna

Authors
  1. Guido Fadda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Grazia Castagna
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria Grazia Castagna.

Ethics declarations

Conflitto di interesse

Gli autori Guido Fadda e Maria Grazia Castagna dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo articolo non hanno eseguito studi sugli animali.

Additional information

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fadda, G., Castagna, M.G. Impatto della diagnosi citologica TIR3a sulle decisioni dell’endocrinologo. L'Endocrinologo 21 (Suppl 1), 56–58 (2020). https://doi.org/10.1007/s40619-020-00718-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-020-00718-y

Search

Navigation